Michael G. Buontempo

Jan 24, 2025 | onlinelibrary.wiley.com | Michael G. Buontempo |Bianca Santos

Emerging evidence suggests a potential association between glucagon-like peptide-1 (GLP-1) receptor agonists and alopecia. Drug-induced hair loss is a recognized adverse effect linked to various medications, including chemotherapeutics, immunosuppressants and certain biologics.1 Recently, semaglutide and tirzepatide—two GLP-1 receptor agonists widely used in managing type 2 diabetes mellitus and obesity—have been implicated in hair loss.